NDRA
$3.32
ENDRA Life Sciences Inc.
Intraday
Recent News
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision
ENDRA posts strong TAEUS Liver study data, showing high measurement reliability for MASLD monitoring and boosting its regulatory and commercial outlook.
Endra Life Sciences commences staking of HYPE digital asset holdings
ENDRA Life Sciences (NDRA) announced it has commenced staking its holdings of HYPE (HYPE-USD), the native token of the Hyperliquid ecosystem. The company said the move is designed to maximize the utility and return of its HYPE treasury. The initiative is guided by ARCA Investment Management and secured by Anchorage Digital. “Commencing our HYPE staking program is an essential evolution of our digital asset strategy,” said Alexander Tokman, CEO of ENDRA. “By partnering with industry leaders ARCA
Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.